Trending

#Formation_Bio

Latest posts tagged with #Formation_Bio on Bluesky

Latest Top
Trending

Posts tagged #Formation_Bio

Preview
Formation Bio Acquires Rights to Innovative Autoimmune Treatment from CTFH Formation Bio expands its portfolio with the acquisition of an innovative oral treatment for autoimmune diseases, enhancing patient care options.

Formation Bio Acquires Rights to Innovative Autoimmune Treatment from CTFH #USA #New_York #Formation_Bio #miR-124 #CTFH

0 0 0 0
Preview
Lynk Pharmaceuticals Collaborates with Formation Bio on Innovative CNS Drug Development Lynk Pharmaceuticals partners with Formation Bio to advance LNK01006, a selective TYK2 inhibitor, into clinical testing and development.

Lynk Pharmaceuticals Collaborates with Formation Bio on Innovative CNS Drug Development #USA #Boston #Formation_Bio #Lynk_Pharmaceuticals #LNK01006

0 0 0 0
Preview
Formation Bio Acquires Rights to Groundbreaking CNS Penetrant TYK2 Inhibitor LNK01006 Formation Bio has secured global rights to LNK01006, a promising CNS-penetrant TYK2 inhibitor from Lynk Pharmaceuticals, enhancing their immunology portfolio.

Formation Bio Acquires Rights to Groundbreaking CNS Penetrant TYK2 Inhibitor LNK01006 #USA #New_York #Formation_Bio #Lynk_Pharmaceuticals #LNK01006

0 0 0 0
Preview
Formation Bio Expands Executive Team to Enhance AI-Driven Drug Development Strategy Formation Bio has appointed top executives from leading biotech and pharma companies to strengthen its AI-driven drug development mission. These appointments are set to transform the company's operational framework to enhance patient outcomes.

Formation Bio Expands Executive Team to Enhance AI-Driven Drug Development Strategy #USA #New_York #AI-driven #Drug_Development #Formation_Bio

0 0 0 0
Preview
Formation Bio Expands Its Immunology Portfolio with New Anti-CD226 License Agreement Formation Bio has secured a license for IMIDomics' first-in-class anti-CD226 monoclonal antibody, targeting autoimmune diseases like ulcerative colitis, promising a new treatment avenue.

Formation Bio Expands Its Immunology Portfolio with New Anti-CD226 License Agreement #USA #New_York #Formation_Bio #IMIDomics #Anti-CD226

0 0 0 0
Preview
Formation Bio Unveils Innovative Entrepreneurs in Residence Program to Boost Drug Development Formation Bio has launched its inaugural Entrepreneurs in Residence program, enlisting top experts to enhance drug development and business growth strategies.

Formation Bio Unveils Innovative Entrepreneurs in Residence Program to Boost Drug Development #USA #New_York #Drug_Development #Formation_Bio #Entrepreneurs_in_Residence

0 0 0 0